Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
7-Keto DHEA for PTSD
NCT01861847Phase 2Completed
- Sponsor
- Humanetics
- Start
- Feb 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of 7-ketodehydroepiandrosterone in post-traumatic stress disorder (PTSD) (2 arms), sponsored by Humanetics. Primary endpoints: Psychological benefits of 7-Keto DHEA at 4 months and Physiological benefits of 7-Keto DHEA at 4 months. Started Feb 2013; status: completed.
02
Drugs
7-ketodehydroepiandrosterone
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT01861847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01861847.